| Tag | Content |
|---|
EnhancerAtlas ID | HS023-13881 |
Organism | Homo sapiens |
Tissue/cell | CD8+ |
Coordinate | chr2:16104910-16106930 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| POU2F2 | MA0507.1 | chr2:16105561-16105574 | TTGATTTGCATAA | + | 6.03 | | Pou2f3 | MA0627.1 | chr2:16105560-16105576 | TTTGATTTGCATAATC | - | 6.25 | | REL | MA0101.1 | chr2:16106079-16106089 | GGAAATCCCC | - | 6.02 | | REST | MA0138.2 | chr2:16105692-16105713 | GGCGCTCTCCGAGGAGCTGAT | - | 7.04 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_68823 | chr2:16105061-16106182 | H9 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 16105769 | 16106162 | | chr2 | 16105224 | 16105375 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I015964 | chr2 | 16105041 | 16105970 |
|
Enhancer Sequence | AGTAGCTGGG ACTATAGGCA TGCACCACTA TGCCTGGATA ATTTTTTTTT TAATATATTT 60
TTGTAGAGAT GGGGTTTTGC CCTGTTGCCC AAGCTGGTCA CAAACTCCTG GGCTCAAGCG 120
ATCTTCCCGC CTCAGCCTCC CAAAGTGTTG GGATTATAAG CATGAGCCAC TGTGCCTGGC 180
TTTACTGATT ATTTTTATAA TTTAAAAAAA TGCAGTCAGC AGAACTAAGA GAGTCCAGGA 240
TAAACCTGAG CAGACACAGC CACACCTTCA GGACCCAGAA CCTGCCTGGC AGCTTCACCT 300
GTCATCAGTT CACTCCAAGT CCACCCTGTC TTGGCAGAGT GCACCCAGGC CCAGACAGAG 360
GAGCCAGGGG AGCCCTGTCC TCAAGAAAGC ACCAAGCTTA GTCTCCGGGG CAAGCCAGGT 420
CCAGAGCCAC AACACAAGTT GTGTGTGGGG TGGAAACAGC TTGCTCTTCC TCGCCTCTGG 480
GCACTGTGGG CATTTGAACT CTGGAGCCAG TGACCTCATC TGTAAAAGGC AGTGAAAATT 540
CCTACCTCAC AAGGTGGCGA GGAGGATTAA ATGAAATAAA CGACTGCAAG GGTTATGTAA 600
ACTGTAGAGT GCCCCACAAA TCGAAGGGAT TATTGTTATC CATTAGCTCA TTTGATTTGC 660
ATAATCCCTC TGAGGTGGGT AGAGGCTATT CCCGTTTTGG GACAGGCTGG TGCTCCCTGC 720
TTCTTTAGGG CCTGAGTCTG TCCTTCGTGC CCAGGAGGCT GGTCTGGTTG GAGGCGGCCC 780
CAGGCGCTCT CCGAGGAGCT GATGGGGTGG GACGCCCTTC TCAGGGAACT CTGGGGCTTC 840
AGAGTGGGCC TTCCTTGGGG ACTGCTCGAC TGTGGCCAGG CCTCCATCCA GCCCTTCAGA 900
GCTGGGGCAG CTCGGTCTGG GGACAGTGTC TCATCGCTCC CTCGCCACAG GGGCCAGGCC 960
CTAATCGCTT TCTTTAGAGG CCTTTGTGCA GCCCGTTCTT TCATTCTGGG CCCAACACAA 1020
TGCAGGGGTG AGCTGAGGTC AGATTTTCCA CCTTCAGCTC TGGATTTCCT GTCTTTTGTC 1080
GGGTGGAGGA CAGATTATGC CACCCGGCTT CCTGTCATCT CAGCACTGGG GGCGCCCCCG 1140
CCCTGGCACC AGCCCACAAC GGGAGAGAGG GAAATCCCCC TGGGGGGTGA AGAGGGAGAA 1200
CCTGCCCTTC ATCCCCAGCC CCTCAGACAT GGGCATTGGC CATCGTTAGA TACTGAGCAT 1260
TTCTTTAGAT CTTTTAGCTG TTGAAAAATG GCTTCTTGTG GGATTTGAAC TCTGATGACA 1320
TCCTACAATA TTTCACCTAA ATATTCTAGA TTAGAAAACA TTATCAGCCC CATTAAACAA 1380
CACGAAATCC TGCCCCTCTT TGGCAGCCCA GATTATGCAA TAAAACACAA TAAGGAATAG 1440
GCCCCTGGTA GCAGAAAGAG GTGGAGGCGG TGGGTATGGA GGGCTGTATT TGTTCCCTTG 1500
GACCACCATA AGAAGGTACC GCAAACTGGG GAGCTACAGC AGCAGAAATG TAGATATCTG 1560
TTCAAGCTGT CAGCAGGGCT GGTTCCTTCT GAAGACCATA ACAGGAAGTG CCCTGGGCGT 1620
CTCCCGTAGC TTATGGTGAC AGATGGTGAT CCTTCCTGCT CCATGGCTTC CTTTGACACG 1680
GTTCTCCCTA AATCTCTGTG TCTTTACATG GGCCTCTTCC CTCTCTGTCC AAAATTCCCT 1740
TTTATTATAA GGACAACAGT TATATGGAAT CGAGGTTCAC TCTACTCCAG TTTGACCTCA 1800
TTTTAACTAA TTACATCTGC AGCATCCCTA TTTCCAAATA AAGTGACATT CTGGGGTACT 1860
GGAGGTCAGG ACTTCAGTAT ATTTTTCGGG GGGACACAAA TCAACTCCAT AACAGGGGGC 1920
CTCTGGTAAG CTAATTTTTT TTTTTTTTTG AGACAGAGTC TCACTCTGTC GCCCAGGCTG 1980
GAGTGCAGTG GTGCGATCTC CACTCACTGT AAGCTCCGCC 2020
|
